OGI
Organigram HoldingsOGI
OGI
About: OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds brands, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
Employees: 898
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
501% more call options, than puts
Call options by funds: $721K | Put options by funds: $120K
47% more capital invested
Capital invested by funds: $8.95M [Q2] → $13.1M (+$4.19M) [Q3]
1.09% more ownership
Funds ownership: 5.61% [Q2] → 6.7% (+1.09%) [Q3]
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
12% less funds holding
Funds holding: 78 [Q2] → 69 (-9) [Q3]
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Research analyst outlook
We haven’t received any recent analyst ratings for OGI.
Financial journalist opinion
Positive
Seeking Alpha
1 month ago
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)
Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cannabis LP Motif Labs which will set Organigram in the top spot in Canada by market share. Organigram has increased its international footprint with an investment in Sanity Group in Germany and in Open Book Extracts in the US.
Neutral
Seeking Alpha
1 month ago
Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Yewon Kang - Canaccord Genuity Operator Good morning. My name is Rob, and I will be your conference operator today.
Positive
Market Watch
1 month ago
Canada's Organigram shops for U.S. pot businesses with backing from British American Tobacco
Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.
Neutral
Business Wire
1 month ago
Organigram Reports Fourth Quarter and Fiscal 2024 Results
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer (“LP”) of cannabis, announced its results for the fourth quarter and twelve months ended September 30, 2024 (“Q4 Fiscal 2024” or “Fiscal 2024”). All financial information in this press release is expressed in Canadian dollars (“$”). Comparable Periods: The Company's results for Q4 Fiscal 2024 and Fiscal 2024 reflect the three-month and 12-month periods ended.
Neutral
Business Wire
1 month ago
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, December 18, 2024 Time: 8:0.
Positive
Market Watch
1 month ago
OrganiGram purchasing Motif Labs to become Canada's largest cannabis company by market share, as others retreat
OrganiGram to pay up to C$100 million ($70.7 million) for vape and prerolled cannabis specialist Motif.
Neutral
Business Wire
1 month ago
Organigram Acquires Motif, Becoming Canada's Largest Cannabis Company by Market Share
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Motif Labs Ltd. (“Motif”), for upfront consideration of $90 million, consisting of $50 million in cash and $40 million of Organigram common shares priced based on the 30 day trading VWAP of $2.3210 on the Toronto Stock Exchange (“TSX”). In addition, Motif share.
Positive
Seeking Alpha
1 month ago
Organigram Could Soar In 2026
Organigram's stock is undervalued, trading at a 22% discount to tangible book value, with strong growth projections and a solid financial outlook. The company has a high cash balance and no debt, bolstered by additional investment from British American Tobacco. Analysts expect revenue and adjusted EBITDA to grow significantly in FY25 and FY26, making the stock a compelling buy.
Neutral
Market Watch
1 month ago
Hemp-based THC revenue may make cannabis stocks more appealing—but there are risks
With cannabis stocks showing steep losses this year on stalled legalization on the U.S. federal level, some companies in the sector are turning to the more thinly-regulated business of THC derived from hemp as a way to potentially excite Wall Street with new revenue streams.
Neutral
Business Wire
1 month ago
Organigram Launches FAST™ Nanoemulsion Gummies
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is thrilled to finally launch Edison Sonics gummies, Organigram's inaugural product powered by FAST™, the Company's groundbreaking nanoemulsion technology and a first-to-market innovation. FAST™ products deliver up to ~50% faster onset and improved bioavailability delivering nearly double the cannabinoids at peak effect compared to traditional ed.
Charts implemented using Lightweight Charts™